Leon Speroff

Leon Speroff's AcademicInfluence.com Rankings

Leon Speroff

Philosophy

#5464

World Rank

#8277

Historical Rank

Logic

#2739

World Rank

#3772

Historical Rank

philosophy Degrees

Leon Speroff

Biology

#7302

World Rank

#10203

Historical Rank

Endocrinology

#71

World Rank

#82

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Why Is Leon Speroff Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Leon Speroff's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical gynecologic endocrinology and infertility (1983) (2882)
Cardiovascular health and disease in women. (1993) (731)
Clinical gynecologic endocrinology and infertility. 8th Ed (2010) (341)
The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. (1996) (270)
Radioimmunoassay of the F prostaglandins. (1971) (257)
Comprar Clinical gynecologic endocrinology and infertility. 8th Ed | Marc Fritz | 9780781779685 | Lippincott Williams & Wilkins (2010) (244)
The effects of an inhibitor of prostaglandin synthesis (indomethacin) on ovulation, pregnancy, and pseudopregnancy in the rabbit. (1972) (200)
A Clinical Guide for Contraception (1992) (200)
Prostaglandin stimulation of in vitro progesterone synthesis. (1970) (181)
EVALUATION OF A NEW GENERATION OF ORAL CONTRACEPTIVES (1993) (177)
Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy. (2009) (177)
Efficacy and Tolerability of Desvenlafaxine Succinate Treatment for Menopausal Vasomotor Symptoms: A Randomized Controlled Trial (2008) (154)
The heart and estrogen/progestin replacement study (HERS). (1998) (152)
Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. (2005) (139)
The postpartum visit: it's time for a change in order to optimally initiate contraception. (2008) (135)
Regional Cardiac Prostaglandin Release during Myocardial Ischemia in Anesthetized Dogs (1976) (123)
The effects of exogenous progesterone and estradiol on prostaglandin F levels in ovariectomized ewes. (1972) (122)
Costs and net health effects of contraceptive methods. (2004) (114)
Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density. (2009) (112)
Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate. (2001) (107)
The endocrinology of the menstrual cycle: the interaction of folliculogenesis and neuroendocrine mechanisms. (1982) (104)
A Comparison of Esterified Estrogens With and Without Methyltestosterone: Effects on Endometrial Histology and Serum Lipoproteins in Postmenopausal Women (1993) (103)
International consensus conference on postmenopausal hormone therapy and the cardiovascular system. (1994) (100)
Radioimmunoassay of the A prostaglandins. (1972) (100)
Ovulation and pregnancy rates with clomiphene citrate. (1978) (97)
Health benefits of oral contraceptives. (2000) (91)
A risk-benefit analysis of elective bilateral oophorectomy: effect of changes in compliance with estrogen therapy on outcome. (1991) (83)
Cardiac prostaglandin release during myocardial ischemia induced by atrial pacing in patients with coronary artery disease. (1977) (83)
Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results. (2003) (82)
The effect of chronic sodium loading and sodium restriction on plasma prostaglandin A, E, and F concentrations in normal humans. (1973) (80)
Estrogen-induced human luteolysis. (1973) (80)
Therapeutic controversy: Estrogen replacement in menopause. (1996) (79)
Efficacy and Local Tolerance of a Low‐Dose, 7‐Day Matrix Estradiol Transdermal System in the Treatment of Menopausal Vasomotor Symptoms (1996) (76)
The effect of aging on fertility. (1994) (76)
Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms. (2003) (75)
Exercise and Menstrual Function. (1980) (74)
The effect of exercise on uterine activity in the last eight weeks of pregnancy. (1985) (73)
Prostaglandins in reproductive physiology. (1970) (66)
Ovarian hyperstimulation syndrome. Report of a case with notes on pathogenesis and treatment. (1972) (64)
Mathematical studies of the human menstrual cycle. I. Formulation of a mathematical model. (1972) (62)
Regulation of the human menstrual cycle. (1971) (61)
A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. (1990) (56)
Estradiol and hemodynamics during ovulation induction. (1986) (54)
Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII. (1988) (52)
Inhibition of progesterone synthesis in vitro by prostaglandin F 2 . (1972) (51)
Prostaglandin F-2 induced steroidogenesis and luteolysis in the primate corpus luteum. (1973) (50)
The effect of angiotensin-II intravenous infusion on plasma renin activity and prostaglandins A, E, and F levels in the uterine vein of the pregnant monkey. (1974) (50)
The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt®) on the frequency and intensity of vasomotor symptoms (2000) (48)
Effects of estrogen and progestin on aortic size and compliance in postmenopausal women. (1996) (48)
L/S Ratio in Predicting Pulmonary Maturity in Utero (1972) (47)
Terbutaline and maternal cardiac function. (1981) (45)
Midtrimester abortion using intraamniotic prostaglandin F2α (1972) (44)
Toxemia of pregnancy (1973) (43)
Hormone levels during prostaglandin F 2 infusions for therapeutic abortion. (1972) (41)
Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. (1991) (40)
A radioimmunoassay for 13, 14-dihydro-15-keto prostaglandin F2alpha with chromatography and internal recovery standard. (1977) (38)
Antihypertensive Function of a Renal-Cell Carcinoma (1974) (38)
Premature ovarian failure: update. (1991) (38)
Clinical gynecologic endocrinology (2012) (36)
The effect of aspirin and indomethacin on the TRH response in man. (1976) (36)
A Clinical Guide for the Care of Older Women: Primary and Preventive Care (1991) (35)
Intravenous prostaglandins E 2 and F 2 for the induction of term labor. (1972) (35)
Transdermal hormone therapy and the risk of stroke and venous thrombosis (2010) (34)
Alternative therapies for postmenopausal women. (2005) (34)
The meaning of mammographic breast density in users of postmenopausal hormone therapy. (2002) (33)
The Effect of Angiotensin II and Indomethacin on Uterine Artery Blood Flow in Pregnant Monkeys (1977) (33)
Estrogen-induced luteolysis in the rhesus monkey: reversal with indomethacin. (1976) (31)
Performance of the TCu380A and Cu-Fix IUDs in an international randomized trail. (1996) (30)
The role of prostaglandin A in the control of sodium homeostasis and blood pressure. (1973) (30)
The perimenopause: definitions, demography, and physiology. (2002) (29)
CLINICAL USE OF PROSTAGLANDINS AS OXYTOCIN SUBSTANCES (1971) (27)
Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy. (2003) (26)
Interrelationships between maternal and cord prolactin, progesterone, estradiol, 13,14-dihydro-15-keto-prostaglandin F2alpha, and cord cortisol at delivery with respect to initiation of parturition. (1978) (26)
Vaginal Bleeding in Postmenopausal Women Taking Low‐Dose Norethindrone Acetate and Ethinyl Estradiol Combinations (2000) (25)
An autoregulatory role for prostaglandins in placental hemodynamics: their possible influence on blood pressure in pregnancy. (1975) (24)
Plasma Estradiol Window and Urinary Estriol Glucuronide Determinations for Monitoring Menotropin Induction of Ovulation (1979) (24)
Development and application of a radioimmunoassay for F prostaglandins. (1972) (23)
Postmenopausal hormone therapy and the risk of breast cancer. (2004) (23)
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 μg) in women with postmenopausal symptoms: Updated analysis of three randomized, controlled trials (2006) (22)
Menopause and hormone replacement therapy. (1993) (21)
A Clinical Understanding of the Estrogen Receptor (2000) (21)
Child development after pregnancies complicated by low urinary estriol excretion and pre-eclampsia. (1972) (20)
Intravenous prostaglandins E 2 and F 2 and syntocinon for the induction of term labor. (1972) (19)
A direct radioimmunoassay for estriol-16-glucuronide in urine for monitoring pregnancy and induction of ovulation. (1977) (19)
An essay: prostaglandins and toxemia of pregnancy. (1973) (19)
The Million Women Study and breast cancer. (2003) (19)
Ultrastructure of the placental villi, chorion laeve, and decidua parietalis in normal and hypertensive pregnant women. (1977) (18)
The distribution of prostaglandins A, E, and F in the human kidney. (1974) (18)
The Menopause: A Signal for the Future (2007) (18)
Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms (2005) (18)
Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch. (2005) (17)
Comprehensive Management of Menopause (2011) (17)
Current concepts of the endocrine characteristics of normal menstrual function: the key to diagnosis and management of menstrual disorders. (1983) (16)
Postmenopausal estrogen–progestin therapy and breast cancer: a clinical response to epidemiological reports (2000) (16)
Toxemia of pregnancy. Mechanism and therapeutic management. (1973) (16)
Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought (2008) (16)
Practical guidelines for postmenopausal hormone therapy. (2005) (16)
The effect of chronic sodium loading and sodium restriction on plasma and renal concentrations of prostaglandin A in normal Wistar and spontaneously hypertensive Aoki rats. (1973) (15)
Techniques of artificial insemination. (1977) (15)
The induction of therapeutic abortion using intravenous prostaglandin F2α (1972) (15)
A statement on abortion by 100 professors of obstetrics: 40 years later. (2013) (15)
Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms (2006) (15)
Prostaglandins and Abortion (1971) (14)
Role of progesterone in normal breast physiology. (1999) (14)
FURTHER CLINICAL STUDIES WITH PROSTAGLANDINS IN REPRODUCTIVE PHYSIOLOGY (1971) (14)
The Perimenopausal Transition (2000) (14)
The formulation of oral contraceptives: does the amount of estrogen make any clinical difference? (1982) (13)
THE ADRENOGENITAL SYNDROME AND ITS OBSTETRICAL ASPECTS. A REVIEW OF THE LITERATURE AND CASE REPORT. (1965) (13)
Postmenopausal hormone therapy and coronary heart disease: clinical implications of recent randomized trial results. (2000) (13)
A practical approach for the evaluation of women with abnormal polytomography or elevated prolactin levels. (1979) (13)
A clinician's review of the WHI-related literature. (2004) (12)
Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation. (2010) (11)
Prostaglandins and pregnancy hypertension. (1977) (11)
The levonorgestrel IUD. (1994) (11)
Oral contraceptives and arterial and venous thrombosis: a clinician's formulation. (1998) (10)
Women's healthcare in the 21st century. (1999) (10)
WHI trial: it's time to be critical! (2003) (10)
Postmenopausal hormone therapy and breast cancer (2004) (10)
Estrogen replacement therapy: current thinking and practice. (1985) (10)
Getting high on running. (1981) (9)
"Performance of the TCu380A and Cu-Fix IUDs in an International Randomized Trial". (1996) (9)
Oral contraceptives and venous thromboembolism (1996) (9)
Uterine artery blood flow studies in the pregnant monkey. (1976) (9)
Endometrial and ovarian cancer and oral contraceptives. (1990) (9)
ESTROGEN-INDUCED HUMAN LUTEOLYSIS (1973) (9)
Clinical Use of Prostaglandins in Reproduction (1973) (9)
Prostaglandins in the control of ovulation, corpus luteum function, and parturition. (1973) (8)
The effect of estradiol infusion on uterine activity and peripheral levels of prostaglandin F and progesterone. (1973) (8)
Comprar A Clinical Guide For Contraception | Leon Speroff | 9781608316106 | Lippincott Williams & Wilkins (2010) (8)
Cardiovascular health and disease in women: coronary heart disease in women: an overview (myths, misperceptions, and missed opportunities) (1993) (8)
Clinical appraisal of the Women's Health Initiative (2005) (8)
The ovary from conception to senescence. (1978) (8)
Therapeutic controversy: The safety of third-generation oral contraceptives. (1999) (8)
Some practical considerations in the radioimmunoassay of the F prostaglandins (1972) (8)
Low-dose hormone therapy in postmenopausal women in China (2010) (8)
Effects of positional change and sodium balance on the renin-angiotensin-aldosterone system, big renin and prostaglandins in normal pregnancy. (1978) (8)
Gonads are the heart of the matter. (2007) (7)
A statement on abortion by 100 professors of obstetrics: 40 years later. (2013) (7)
Postmenopausal hormone therapy and primary prevention of cardiovascular disease -- Nurses' health study 20-year follow-up. (2001) (7)
The Impact of the Women's Health Initiative on Clinical Practice (2002) (7)
Adrenal morphologic considerations in polycystic ovary syndrome. (1990) (7)
The impact of the Women's Health Initiative on clinical practice. (2002) (7)
Bacterial shock in obstetrics and gynecology; with emphasis on the surgical management of septic abortion. (1966) (7)
The risk of breast cancer associated with oral contraception and hormone replacement therapy. (1992) (7)
Postmenopausal hormone therapy and breast cancer. (1996) (7)
Postmenopausal hormone therapy into the 21st century (1997) (7)
A clinician's response to the oral contraceptive thrombosis controversy. (1999) (6)
WHI estrogen-only arm is canceled. (2004) (6)
DISCUSSION OF SESSION ON PROSTAGLANDINS IN FEMALE REPRODUCTIVE PHYSIOLOGY (1971) (6)
Contraceptive choices for women with medical problems. (1993) (6)
Ethics and referral for abortion. (2009) (6)
Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view. (2004) (5)
It's time to stop using the word 'replacement'. (2000) (5)
Postmenopausal estrogen-progestin therapy and breast cancer (2000) (5)
Postmenopausal hormone therapy and cardiovascular disease: one view of the elephant. (2005) (5)
The Bleeding Corpus Luteum: Analysis of 40 Confirmed Cases (1966) (5)
Oral contraception for women in their 40s. (1990) (5)
Preventive health care for older women. (1996) (5)
Cover Story: Is tibolone a viable alternative to HT? (2003) (5)
Midtrimester abortion using intra-amniotic prostaglandin F2 alpha with intravenous Syntocinon. (1972) (4)
Does exposure of preovulatory oocytes to ultrasonic radiation affect reproductive performance? (1988) (4)
Postmenopausal hormone therapy and the cardiovascular system. (1994) (4)
Hormone Replacement Therapy: Clarifying the Picture (2001) (4)
The future of postmenopausal hormone therapy: It's time to move forward. (2007) (4)
Midtrimester therapeutic abortion using intraamniotic PGF2alpha. (1973) (4)
Lactogenic Hormones. A Ciba Foundation Symposium (1973) (4)
Postmenopausal hormone therapy and breast cancer: a clinician's message for patients. (2004) (4)
Which birth control pill should be prescribed? (1976) (4)
PHYSIOLOGIC AND PHARMACOLOGIC ROLES FOR PROSTAGLANDINS IN OBSTETRICS (1973) (4)
Endometrial cancer--surprising reports. (2005) (4)
Is postmenopausal estrogen use risky results from a methodologic review and information synthesis (1987) (3)
The case for postmenopausal hormone therapy. (1996) (3)
Menstrual Dysfunction and Hormonal Status in Athletic Women (1982) (3)
The effects of oral contraceptives on reproduction. (1989) (3)
Contraception in the later reproductive years: a valid aspect of preventive health care. (1995) (3)
The LIBERATE tibolone trial in breast cancer survivors. (2009) (3)
Impact of exercise on menstruation and reproduction. Symposium. (1982) (3)
Guest Editorial: What have we learned from the WHI? (2007) (2)
HT. A clinician demurs. (2003) (2)
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. (2006) (2)
Cover Story: Management of the perimenopausal transition (2000) (2)
CHAPTER 38 – Interventions for the Control of Symptoms (2000) (2)
Premenopausal atherosclerosis: Setting the stage for later clinical disease (2007) (2)
A brief for low-dose pills. (1981) (2)
The Role of Progestational Agents in Hormone Replacement Therapy (1983) (2)
Endometrial safety with lower doses of conjugated equine estrogens (CEE) and medroxyprogesterone acetate (MPA). (2001) (2)
Which birth control pill should be prescribed--today? (1987) (2)
The induction of therapeutic abortion using intravenous prostaglandin F 2 alpha. (1972) (1)
Depot Medroxyprogesterone Acetate and Bone Density (2009) (1)
Oral contraceptives and arterial and venous thrombosis : A clinician's formulation : Supplement-Mircette: A Novel oral contraceptive (1998) (1)
Modern Low-Dose Oral Contraceptives Are Very Safe (1999) (1)
Prostaglandins and reproduction (1983) (1)
Managing galactorrhea in pill patients. (1981) (1)
Leon Speroff, MD, describes the growth and evolution of reproductive endocrinology (2008) (1)
Postmenopausal estrogen therapy and ovarian cancer (2001) (1)
Oral contraceptives and breast Cancer risk : Summary and application of data (2000) (1)
The Story of Dr. Sidney R. Garfield: The Visionary Who Turned Sick Care into Health Care by Tom Debley, Jon Stewart (2009) (1)
Cardiovascular Disease and Postmenopausal Hormone Replacement Therapy (1991) (1)
Is a transdermal patch more likely to cause VTE than an OC (2007) (1)
Postmenopausal HRT and CHD: clinical implications of recent randomized trial res (2000) (1)
Bone mineral density and hormonal contraception. (2002) (1)
The meaning of mammographic breast density in users of postmenopausal HRT (2002) (1)
Clinical Gynecologic Endocrinology and Infertility: Self Assessment and Study Guide (1995) (1)
Treating the perimenopausal patient. (1993) (1)
Interim Safety Analysis of a 2-Year Study Comparing Oral Estrogen-Androgen and Conjugated Estrogens in Surgically Menopausal Women: P-75. (1995) (1)
THE COMPARATIVE EFFECT ON BONE DENSITY, ENDOMETRIUM, AND LIPIDS OF CONTINUOUS HORMONES AS REPLACEMENT THERAPY (CHART STUDY) : A RANDOMIZED CONTROLLED TRIAL (1997) (1)
Midtrimester abortion using intraamniotic prostaglandin F2alpha. (1972) (1)
P307 A two-vear study with low dose, continuous, unopposed esterified estrogens: Prevention of postmenopausal bone loss with minimal endometrial effects (1996) (1)
Pentobarbital anesthesia: lack of effect on venous prostaglandins in dogs. (1976) (1)
Prescribing OCs for safety. Symposium. (1986) (1)
Research in a community hospital: some lessons from the Clarkson-Schnatz mentor-mentee pair in The North American Menopause Society Mentorship Program. (2011) (1)
Women’s Hormonal Health Issues (2015) (1)
Which Oral Contraceptive Pill Should be Prescribed (1993) (1)
A quarter century of contraception: remarkable advances increasing success. (1998) (1)
Menopausal health is scientifically and clinically important. (1993) (1)
Editor's Formulation (1983) (1)
Pathophysiologic basis for the menopause. (1985) (1)
A Good Man: Gregory Pincus & the Development of the Oral Contraceptive. (2011) (0)
Critical comments. (2003) (0)
Using aromatase inhibitors to treat early breast cancer (2006) (0)
Hormonal Contraception (1973) (0)
AAAG: Evaluating the evidence for aromatase inhibitors to treat early breast cancer (2007) (0)
90068857 A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement (1990) (0)
More Peering Into Editorial Peer Review (2017) (0)
Maintaining excellence in obstetrics and gynecology (2017) (0)
Clinical Gynecologic Endocrinology and Infertility/ Speroff,Leon (1989) (0)
A possible control mechanism for the synthesis and release of prostaglandin A from the kidney. (1973) (0)
Postmenopausal hormone therapy into the 21st century. (1997) (0)
A tender subject (2010) (0)
Changing from an oral contraceptive to hormone replacement therapy for menopause. (1990) (0)
Book ReviewUterine Contraction: Side effects of steroidal contraceptives. (1973) (0)
Low Dose Esterified Estrogens: Prevention of Postmenopausal Bone Loss Without Development of Endometrial Hyperplasia: S-3. (1996) (0)
Oral contraceptives and breast cancer (1969) (0)
Endocrinology and pharmacology: a panel discussion. (1986) (0)
A fitness trainer becomes a professor: the Henderson-Elavsky mentor-mentee pair in The North American Menopause Society Mentorship Program (2011) (0)
The Quest for Cortisone by Thom Rooke (2012) Michigan State University Press East Lansing, MI, USA. (2012) (0)
Premature ovarian failure. (1995) (0)
I170 E2V/DNG: contraceptive efficacy and safety data (2009) (0)
S-11.: Increased Bone Mineral Density in Surgically Menopausal Women Treated with Oral Estrogen-Androgen (1997) (0)
Experts offer advice on testosterone testing and whether to discontinue hormone therapy before surgery. (2008) (0)
Think about it! The North American Menopause Society Mentorship Program. (2010) (0)
Antihypertensive function of renal-cell carcinoma. Evidence for a prostaglandin-A-secreting tumor. (1974) (0)
A Matter of Perspective (1961) (0)
Sign Out: What I've learned from the emotional and political response to WHI (2004) (0)
Cardiovascular disease and pregnancy: maternal cardiac disease: the obstetrician's viewpoint (1995) (0)
Functional ovarian cysts and lower-dose formulations. (1990) (0)
Cervical neoplasms and oral contraceptives. (1990) (0)
Safety of oral contraception: a quarrel with the recent literature. (1984) (0)
The management of bacterial shock and septic abortion. (1966) (0)
Management of Adult and Perimenopausal Dysfunctional Uterine Bleeding and Current Use of Hormonal Replacement Therapy (1991) (0)
Clinical problems with oral contraceptives. (1977) (0)
Estrogen Replacement Therapy: New Options, Continuing Concerns-Reply (1997) (0)
Continuing Medical Care of the Menopausal Woman (1994) (0)
Cardiovascular safety of current oral contraceptives for nonsmoking women. (1990) (0)
ESTROGEN REPLACEMENT THERAPY: NEW OPTIONS, CONTINUING CONCERNS. AUTHORS' REPLY (1997) (0)
How and When to Use the New Forms of Hormone Replacement Therapy (1998) (0)
Festschrift for Peter Kenemans (2007) (0)
Letter to the editor in response to "omissions, biases, and nondisclosed conflicts of interest: Is there a hidden agenda in the NAMS position statement?" (2005) (0)
The female athlete and contraceptive hormones. (2001) (0)
Cycle control with lower-dose formulations of oral contraceptives. (1990) (0)
Multiphasic and monophasic OCs: is there a difference? (1988) (0)
Therapeutic Benefits and Tolerability of Long-term Treatment with Estrogen or Estrogen-androgen: P-11. (1996) (0)
An ocean between: the Archer-Stute mentor-mentee pair in The North American Menopause Society Mentorship Program. (2011) (0)
Book ReviewClinical in Vitro Fertilization (1985) (0)
Sea to sea: Manson-Shufelt, mentor-mentee in The North American Menopause Society Mentorship Program. (2011) (0)
The Prostaglandins—Enthusiasm and Caution in Equal Doses (1971) (0)
A 37-Year-Old Man With Multiple Somatic Complaints, 1 Year Later (2017) (0)
HRT beyond the menopause — adding value to added years (1997) (0)
Isolating the cause of amenorrhea. (1977) (0)
Critical Comment Postmenopausal hormone therapy and primary prevention of cardiovascular disease — Nurses' health study 20-year follow-up (2001) (0)
Laparoscopic uterine artery occlusion versus uterine fibroid embolization (2006) (0)
Mircette: a novel oral contraceptive. Introduction. (1998) (0)
The transitional pill. (1990) (0)
Clinical profile of 24-day oral contraceptives (2007) (0)
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.[erratum appears in Clin Ther. 2006 Aug;28(8):1244] (2006) (0)
Endometrial histologic effects of oral micronized progesterone in estrogen‐treated postmenopausal women (2000) (0)
Book ReviewHandbook of Physiology, Section 7: Endocrinology, Vol. 2: Female Reproductive System, Part 1. (1974) (0)
Endometrial Histologic Effects of Oral Micronized Progesterone in Estrogen-Treated Postmenopausal Women (2000) (0)
Important clinical roles for steroid hormone receptors. (1978) (0)
Results of tubal plastic surgery at the Columbia-Presbyterian Medical Center 1955-1968. (1973) (0)
Marked changes in the circulating levels and ratios of angiopoietins during pregnancy, compared to natural menstrual cycles and controlled ovarian stimulation (2007) (0)
Preoperative and Postoperative Management of the Patient Undergoing Infertility Surgery (1984) (0)
'Postmenopausal hormone therapy and coronary heart disease - Clinical implications of recent randomized trial results' by Leon Speroff (2000) (0)
A journey of love: the Wild-Farhi mentor-mentee pair in The North American Menopause Society Mentorship Program (2011) (0)
Comparing the monkey and human data on tibolone (2003) (0)
Effects of low-dose oral contraceptives on blood lipids. (1990) (0)
Sign Out: Meta-analysis is to analysis like meta-physics is to physics (2007) (0)
The use of prostaglandins for the induction of labor. (1973) (0)
Oh by the way. . .what about my headaches (2006) (0)
Flash of insight or flush of confusion? (2010) (0)
Anovulation and cancer. (1984) (0)
It is with immense gratitude that I acknowledge all those who have participated in the Journal's peer-review process in 1998. I would like to extend my sincere thanks for their loyalty and hard work. (1998) (0)
Putting the WHI report on breast cancer into perspective (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Leon Speroff?

Leon Speroff is affiliated with the following schools:

Yale University

Leon Speroff's Academic­Influence.com Rankings

Why Is Leon Speroff Influential?

Leon Speroff's Published Works

Published Works

What Schools Are Affiliated With Leon Speroff?

Leon Speroff's AcademicInfluence.com Rankings